Skip to main content Accessibility help
×
Home
  • Print publication year: 2013
  • Online publication date: March 2013

Section 5 - Post-therapy considerations

References

1. National Cancer Institute. Estimated US cancer prevalence. cancercontrol.cancer.gov/ocs/prevalence/prevalence.html#survivor (accessed January 2012).
2. Altekruse SF, Kosary CL, Krapcho M, et al. SEER Cancer Statistics Review, 1975–2007. Bethesda, MD: National Cancer Institute. seer.cancer.gov/csr/1975_2007, based on November 2009 SEER data submission, posted to the SEER website, 2010 (accessed January 2012).
3.Summary of changes in cancer mortality,1950–2007 and 5-year relative survival rates, 1950–2006 males and females, by primary cancer site. seer.cancer.gov/csr/1975_2007/browse_csr.php?section=1&page=sect_01_table.03.html (accessed January 2012).
4. Lee SJ, Schover LR, Partridge AH, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 2006; 24: 2917–31.
5.Multidisciplinary Working Group convened by the British Fertility Society. A strategy for fertility services for survivors of childhood cancer. Hum Fertil (Camb) 2003; 6: A1–39.
6. European Society of Human Reproduction and Embryology (ESHRE) Task Force on Fertility Preservation in Severe Diseases. www.eshre.eu/01/default.aspx?pageid=29 (accessed January 2012).
7.Ethics Committee of the American Society for Reproductive Medicine. Fertility preservation and reproduction in cancer patients. Fertil Steril 2005; 83: 1622–8.
8. Lass A, Akagbosu F, Brinsden P. Sperm banking and assisted reproduction treatment for couples following cancer treatment of the male partner. Hum Reprod Update 2001; 7: 370–7.
9. Quinn GP, Vadaparampil ST, Gwede CK, et al. Discussion of fertility preservation with newly diagnosed patients: oncologists views. J Cancer Surviv 2007; 1: 146–55.
10. Quinn GP, Vadaparampil ST, Bell-Ellison BA, Gwede CK, and Albrecht TL. Patient-physician communication barriers regarding fertility preservation among newly diagnosed cancer patients. Soc Sci Med 2007; 66: 784–9.
11. Schover LR. Psychosocial aspects of infertility and decisions about reproduction in young cancer survivors: a review. Med Pediatr Oncol 1999; 33: 53–9.
12. Schover LR, Brey K, Lichtin A, Lipshultz LI, Jeha S. Oncologists’ attitudes and practices regarding banking sperm before cancer treatment. J Clin Oncol 2002; 20: 1890–7.
13. Anderson RA, Weddell A, Spoudeas HA, et al. Do doctors discuss fertility issues before they treat young patients with cancer? Hum Reprod 2008; 23: 2246–51.
14. Crawshaw M, Glaser A, Hale J, Sloper P. Professionals’ views on the issues and challenges arising from providing a fertility preservation service through sperm banking to teenage males with cancer. Hum Fertil 2004; 7: 23–30.
15. Van den Berg H, Langeveld NE. Parental knowledge of fertility in male childhood cancer survivors. Psychooncology 2008; 17: 287–91.
16. Goodwin T, Oosterhuis EB, Kierman M, Hudson GV. Attitudes and practices of pediatric oncology providers regarding fertility issues. Pediatric Blood Cancer 2007; 48: 80–5.
17. Tschudin S, Bitzer J. Psychological aspects of fertility preservation in men and women affected by cancer and other life-threatening diseases. Human Reprod Update 2009; 15: 587–97.
18. Rosen A, Rodriguez-Wallberg K, Oktay K. Psychological issues of cancer survivors. In Donnez J, Kim SS, eds. Principles and Practice of Fertility Preservation. Cambridge: Cambridge University Press, 2011; pp. 473–84.
19. Rosen A, Rodriguez-Wallberg KA, Rosenzweig L. Psychosocial distress in young cancer survivors. Semin Oncol Nurs 2009; 25: 268–77.
20. Schover LR, Rybicki LA, Martin BA, Bringelsen KA. Having children after cancer: a pilot survey of survivors’ attitudes and experiences. Cancer 1999; 86: 697–709.
21. Schover LR, Brey K, Lichtin A, Lipshultz LI, Jeha S. Knowledge and experience regarding cancer, infertility, and sperm banking in younger male survivors. J Clin Oncol 2002; 20: 1880–9.
22. Saito K, Suzuki K, Iwasaki A, Yumura Y, Kubota Y. Sperm cryopreservation before cancer chemotherapy helps in the emotional battle against cancer. Cancer 2005; 104: 521–4.
23. Oosterhuis EB, Goodwin T, Kiernan M, Hudson MM, Dahl GV. Concerns about infertility risks among pediatric oncology patients and their parents. Pediatr Blood Cancer 2008; 50: 85–9.
24. Oppenheim D, Brugieres L, Hartmann O. Adolescents treated for cancer and fertility preservation. Psychological aspects. Gynecol Obstet Fertil 2005; 33: 627–31.
25. Green D, Galvin H, Horne B. The psycho-social impact of infertility on young male cancer survivors: a qualitative investigation. Psychooncology 2003; 12: 141–52.
26. Zapzalka D, Redmon J, Pryor J. A survey of oncologists regarding sperm cryopreservation and assisted reproductive techniques for male cancer patients. Cancer 1999; 86: 1812–17.
27. Schover LR. Sexuality and Fertility after Cancer. New York, NY: Wiley, 1997.
28. Schover LR, Thomas AJ. Overcoming Male Infertility: Understanding its Causes and Treatments. New York, NY: Wiley, 2000.
29. American Cancer Society. Fertility and cancer: what are my options? www.cancer.org/Treatment/TreatmentsandSideEffects/PhysicalSideEffects/FertilityandCancerWhatAreMyOptions/fertility-and-cancer (accessed January 2012).
30.Live on: sperm banking by mail. www.liveonkit.com (accessed January 2012).
31. Merckaert I, Libert Y, Messin S, et al. Cancer patients’ desire of psychological support: prevalence and implications for screening patients’ psychological need. Psychooncology 2010; 19: 141–9.
32. Strong V, Waters R, Hibberd C, et al. Emotional distress in cancer patients: the Edinburgh Cancer Centre symptom study. Br J Cancer 2007; 96: 868–74.
33. Crawshaw MA, Glaser AW, Hale JP, Sloper P. Male and female experiences of having fertility matter raised alongside a cancer diagnosis during the teenage and young adult years. Eur J Cancer Care 2009; 18: 381–90.
34. Nachtigall R, Becker G, Wozny M. The effects of gender specific diagnosis on men's and women's response to infertility. Fertil Steril 1992; 57: 113–21.
35. Mason MC. Male Infertility: Men Talking. London: Routledge, 1993.
36. Leiblum S, Kennan E, Lane M. The psychological concomitants of in vitro fertilization. J Psychosom Obstet Gynaecol 1987; 6: 165–78.
37. Glover L, Abel P, Gannon K. Male subfertility: is pregnancy the only issue? Psychological responses matter too – and are different in men. BMJ 1998; 316: 405–6.
38. Berg B, Wilson J, Weingartner P. Psychological sequelae of infertility treatment: the role of gender and sex-role identification. Soc Sci Med 1991; 33: 1071–80.
39. Petok W. The psychology of gender-specific infertility diagnoses. In Covington S, Hammer Burns L, eds. Infertility Counseling: A Comprehensive Handbook for Clinicians, 2nd edn. New York, NY: Cambridge University Press, 2006; pp. 37–60.
40. Newton C. Counseling the infertile couple. In Covington S, Hammer Burns L, eds. Infertility Counseling: A Comprehensive Handbook for Clinicians, 2nd edn. New York, NY: Cambridge University Press, 2006; pp.143–55.
41. Connolly K, Edelmann R, Cook I. Distress and marital problems associated with infertility. J Reprod Infant Psychol 1987; 5: 49–57.
42. Irvine S. Male infertility and its effect on male sexuality. Sex Marital Ther 1996; 11: 273–80.
43. Rieker P, Fitzergerald E, Kalish L. Adaptive behavioral responses to potential infertility among survivors of testis cancer. J Clin Oncol 1990; 8: 347–55.
44. Mikulincer M, Horesh N, Levy-Shiff R, et al. The contribution of adult attachment style to the adjustment to infertility. Br J Med Psychol 1998; 71: 265–80.
45. Daniluk J. Gender and infertility. In Leiblum SR, ed. Infertility: Psychological Issues and Counseling Strategies. New York, NY: Wiley, 1997; pp. 103–25.
46. Stanton A. Cognitive appraisals, coping processes, and adjustment to infertility. In Stanton A, Dunkel-Schetter C, eds. Infertility: Perspectives from Stress and Coping Research. New York, NY: Plenum, 1991; pp. 87–108.
47. Thorn P. Recipient counseling for donor insemination. In Covington S, Hammer Burns L, eds. Infertility Counseling: A Comprehensive Handbook for Clinicians, 2nd edn. New York, NY: Cambridge University Press, 2006; pp.305–318.
48. Peck P. Anonymous sperm donation. www.medicinenet.com/script/main/art.asp?articlekey=50877 (accessed January 2012).
49.Sperm donation. en.wikipedia.org/wiki/Sperm_donation (accessed January 2012).
50. Sperm Bank of California. Donor screening process. www.thespermbankofca.org/content/donor-screening-process (accessed January 2012).
51. American Sociological Association. Sperm donors valued less than egg donors. www.sciencedaily.com/releases/2007/05/070525204143.htm, posted May 26, 2007 (accessed January 2012).
52. Wanjek C. The good, the bad and the ugly sperm. LiveScience. www.livescience.com/10462-good-bad-ugly-sperm.html (accessed January 2012).
53. Orlando L. FDA recommends barring gay men from being sperm donors. www.buzzle.com/editorials/6-7-2005-71220.asp (accessed January 2012).
54.Sperm bank ban in Turkey sparks debate. Daily News Economic Review. www.hurriyetdailynews.com/n.php?n=sperm-bank-ban-sparks-debate-2010-07-30, posted July 30, 2010 (accessed January 2012).
55. Boggio A. Italy enacts new law on medically assisted reproduction. Hum Reprod 2005; 20: 1153–7.
56. Amuzu B, Laxoca R, Shapiro S. Pregnancy outcome, health of children and family adjustment after donor insemination. Obstet Gynecol 1990; 75: 899–905.
57. Milson I, Bergman P. A study of parental attitudes after donor insemination (AID). Acta Obstet Gynecol Scand 1982; 61: 125–8.
58. Clayton C, Kovacs GT. AID offspring: initial follow-up of 50 couples. Med J Aust 1982; 1: 338–9.
59. Lansac J and Royère D. Follow-up studies of children born after frozen sperm donation. Hum Reprod Update 2001; 7: 33–7.
60. Brewaeys A. Parent–child relationships and child development in donor insemination families. Hum Reprod Update 2001; 7: 38–46.
61. Gillet W, Daniels K, Herbison G. Feelings of couples who have had a child by donor insemination. The degree of congruence. J Psychsom Obstet Gynecol 1996; 17: 135–42.
62. Golombok S, Brewaeys A, Giavazzi M, et al. The European study of assisted reproduction families: the transition into adolescence. Hum Reprod 2002; 17: 830–40.
63. Golombok S, Jadva V, Lycett E, et al. Families created by gamete donation. Follow-up at age 2. Hum Reprod 2005; 20: 286–93.
64. Daniels K. Adoption and donor insemination: factors affecting couples’ choices. Child Welfare 1994; 73: 1473–80.
65. Baran A, Pannor R. The Psychology of Donor Insemination, 2nd edn. New York, NY: Amistad, 1993.
66. Rosen A. Third-party reproduction and adoption in cancer patients. J Natl Cancer Inst Monogr 2005; 34: 91–3.
67. Rosen A. Fertility, pregnancy and adoption: knowing your options. SHARE Adoption Program. Presented September 28, 2010. vimeo.com/17158077 (accessed January 2012).
68. Canadian Women's Health Network. Bill C-6: an Act respecting assisted human reproduction and related research, 2004. www.cwhn.ca/resources/cwhn/billc6.html (accessed January 2012).
69. Daniels K. New Zealand: from secrecy and shame to openness and acceptance. In: Blyth E, Landau R, eds. Third-Party Assisted Conception Across Cultures: Social, Legal and Ethical Perspectives. London: Jessica Kinsley, 2004; pp. 148–67.
70. American Society for Reproductive Medicine. Informing offspring of their conception by gamete donation. Fertil Steril 2004; 81: 527–31.
71. Sachs P, Burns LH. Recipient counseling for oocyte donation. In Covington S, Hammer Burns L, eds. Infertility Counseling: A Comprehensive Handbook for Clinicians, 2nd edn. New York, NY: Cambridge University Press, 2006; pp.319–38.
72. Ethics Committee of the American Society for Reproductive Medicine. Child-rearing ability and the provisions for fertility services. Fertil Steril 2004; 82: 564–7.
73. Klock S. To tell or not to tell: the issue of privacy and disclosure. In Leiblum S, ed. Infertility, Psychological Issues and Counselling Strategies. New York, NY: Wiley, 1997; pp. 167–88.
74. Cook R, Golombok S, Bish A. et al. Disclosure of donor insemination: Parental attitudes. Am J Orthopsychiatry 1995; 65: 549–59.
75. Nachtigall R, Becker G, Szupinski Quigora S, et al. The disclosure decision: concerns and issues of parents of children conceived through donor insemination. Am J Obstet Gynecol 1998; 178: 1165–70.
76. Lindblad F, Gottlieb C, Lalos O. To tell or not to tell: what parents think about telling their children that they were born following donor insemination. J Psychosom Obstet Gynecol 2000; 21: 193–203.
77. Rumball A, Adair A. Telling the story: parents’ scripts for donor offspring. Hum Reprod 1999; 14: 1392–9.
78. Gottlieb C, Lalos O, Lindblad R. Disclosure of donor insemination to the child: the impact of Swedish legislation on couples’ attitudes. Hum Reprod 2000; 15: 2052–6.

References

1. Collins JA, Wrixon W, Janes LB, Wilson EH. Treatment-independent pregnancy among infertile couples. N Engl J Med 1983; 309: 1201–6.
2. Honig SC, Lipshultz LI, Jarow J. Significant medical pathology uncovered by a comprehensive male infertility evaluation. Fertil Steril 1994; 62: 1028–34.
3. AndroGel [package insert]. Marietta, GA: Unimed Pharmaceuticals, LLC, 2007.
4. Baskin HJ, Cobin RH, Duick DS, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract 2002; 8: 457–69.
5. Wang C, Catlin DH, Demers LM, Stacevic B, Swerdloff RS. Measurement of total serum testosterone in adult men: comparison of current laboratory methods versus liquid chromatography-tandem mass spectrometry. J Clin Endocrinol Metab 1999; 89: 534–43.
6. Bhasin S. Testicular disorders. In Kronenberg HM, Melmed S, Polonsky KS, Reed Larsen P, eds. Williams Textbook of Endocrinology, 11th edn. Philadelphia, PA: Saunders, 2008.
7. Vermeulen A, Vedonck L, Kaufman JM. A clinical evaluation of simple methods for the estimations of free testosterone in serum. J Clin Endocrinol Metab 1999; 84: 3666–72.
8. Raman JD, Schlegel PN. Aromatase inhibitors for male infertility. J Urol 2002; 167: 624–9.
9. Schoor RA, Elhanbly S, Niederberger CS, Ross LS. The role of testicular biopsy in the modern management of male infertility. J Urol 2002; 167: 197–200.
10. Kumanov P, Nandipati K, Tomova A, Agarwal A. Inhibin B is a better marker of spermatogenesis than other hormones in the evaluation of male factor infertility. Fertil Steril 2006; 86: 332–8.
11. Mellinger RC, Thompson RJ. The effect of clomiphene citrate in male infertility. Fertil Steril 1966; 17: 94–103.
12. Loose D, Stancel G. Estrogens and progestins. In Brunton LL, Lazo JS, Parker KL, eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics, 11th edn. New York, NY: McGraw-Hill, 2006.
13. Heller CG, Rowley MJ, Heller GV. Clomiphene citrate: a correlation of its effect on sperm concentration and morphology, total gonadotropins, ICSH, estrogen and testosterone excretion, and testicular cytology in normal men. J Clin Endocrinol Metab 1969; 29: 638–49.
14. Sigman M, Jarow J. Male infertility. In Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA. Campbell–Walsh Urology, 9th edn. Philadelphia, PA: Saunders, 2007.
15. Paulson DF. Cortisone acetate versus clomiphene citrate in pre-germinal idiopathic oligospermia. J Urol 1979; 121: 432–4.
16. Wang C, Chan CW, Wong KK, Yeung KK. Comparison of the effectiveness of placebo, clomiphene citrate, mesterolone, pentoxyfylline, and testosterone rebound therapy for the treatment of idiopathic oligospermia. Fertil Steril 1983; 40: 358–65.
17. Check JH, Chase JS, Nowroozi K, Wu CH, Adelson HG. Empirical therapy of the male with clomiphene in couples with unexplained fertility. Int J Fertil 1989; 34: 120–2.
18. Akin JW. The use of clomiphene citrate in the treatment of azoospermia secondary to incomplete androgen resistance. Fertil Steril 1993; 59: 223–4.
19. Hussein A, Ozgok Y, Ross L, Niederberger C. Clomiphene administration for cases of nonobstructive azoospermia: a multicenter study. J Androl 2005; 26: 787–91.
20. Whitten SJ, Nangia AK, Kolettis PN. Select patients with hypogonadotropic hypogonadism may respond to treatment with clomiphene citrate. Fertil Steril 2006; 86: 1664–8.
21. Ghanem H, Shaeer O, El-Segini A. Combination clomiphene citrate and antioxidant therapy for idiopathic male infertility: a randomized controlled trial. Fertil Steril 2010; 93: 2232–5.
22. Vermeulen A, Comhaire F. Hormonal effects of an antiestrogen, tamoxifen, in normal and oligospermic men. Fertil Steril 1978; 29: 320–7.
23. Boyle K. Nonsurgical treatment of male infertility: empiric therapy. In Lipshultz L, Howards S, Niederberger C, eds. Infertility in the Male, 4th edn. Cambridge: Cambridge University Press, 2009.
24. Adamopouos DA, Pappa A, Billa E, et al. Effectiveness of combined tamoxifen citrate and testosterone undecanoate treatment in men with idiopathic oligozoospermia. Fertil Steril 2003; 80: 914–20.
25. Raman J, Schlegel P. Aromatase inhibitors for male infertility. J Urol 2002; 167: 624–9.
26. Liu L, Chaudhari N, Corle D, Sherins RJ. Comparison of pulsatile subcutaneous gonadotropin-releasing hormone and exogenous gonadotropins in the treatment of men with isolated hypogonadotropic hypogonadism. Fertil Steril 1988; 49: 302–8.
27. Miyagawa Y, Tsujimura A, Matsumiya K, et al. Outcome of gonadotropin therapy for male hypogonadotrophic hypogonadism at university affiliated male infertility centers: a 30-year retrospective study. J Urol 2005; 173: 2072–5.
28. Knuth UA, Hönigl W, Bals-Pratsch M, Schleicher G, Nieschlag E. Treatment of severe oligospermia with human chorionic gonadotropin/human menopausal gonadotropin: a placebo-controlled, double blind trial. J Clin Endocrinol Metab 1987; 65: 1081–7.
29. Caroppo E, Niederberger C, Vizziello GM, D’Amato G. Recombinant human follicle-stimulating hormone as a pretreatment for idiopathic oligoasthenoterato-zoospermic patients undergoing intracytoplasmic sperm injection. Fertil Steril 2003; 80: 1398–403.
30. Foresta C, Bettella A, Garolla A, Ambrosini G, Ferlin A. Treatment of male idiopathic infertility with recombinant human follicle-stimulating hormone: a prospective, controlled, randomized clinical study. Fertil Steril 2005; 84: 654–61.
31. Coviello AD, Bremner WJ, Matsumoto AM, et al. Intratesticular testosterone concentrations comparable with serum levels are not sufficient to maintain normal sperm production in men receiving a hormonal contraceptive regimen. J Androl 2004; 25: 931–8.
32. World Health Organization. Mesterolone and idiopathic male infertility: a double-blind study. Int J Androl 1989; 12: 254–64.
33. Balercia G, Buldreghini E, Vignini A, et al. Coenzyme Q10 treatment in infertile men with idiopathic asthenozoospermia: a placebo-controlled, double-blind randomized trial. Fertil Steril 2009; 91: 1785–92.
34. Sarafinejad M. Efficacy of coenzyme Q10 on semen parameters, sperm function and reproductive hormones in infertile men. J Urol 2009; 182: 237–48.
35. Agarwal A, Sharma RK, Nallella KP, et al. Reactive oxygen species as an independent marker of male factor infertility. Fertil Steril 2006; 86: 878–85.
36. Mills J, Meacham R. Nonsurgical treatment of male infertility: specific therapy. In Lipshultz L, Howards S, Niederberger C, eds. Infertility in the Male, 4th edn. Cambridge: Cambridge University Press, 2009.
37. Gillam MP, Molitch ME, Lombardi G, Colao A. Advances in the treatment of prolactinomas. Endocr Rev 2006; 27: 485–534.
38. De Rosa M, Colao A, Di Sarno A, et al. Cabergoline treatment rapidly improves gonadal function in hyperprolactinemic males: a comparison with bromocriptine. Eur J Endocrinol 1998; 138: 286–93.
39. Bar-Chama N, Goluboff E, Fisch H. Infection and pyospermia in male infertility: is it really a problem? Urol Clin North Am 1994; 21: 469–75.
40. Gonzales FG, Munoz G, Sanches R, et al. Update on the impact of Chlamydia trachomatis infection on male fertility. Andrologia 2004; 36: 1–23.
41. de Barbeyrac B, Papaxanthos-Roche A, Mathieu C, et al. Chlamydia trachomatis in subfertile couples undergoing an in vitro fertilization program: a prospective study. Eur J Obstet Gyneol Reprod Biol 2006; 129: 46–53.
42. Kasturi S, Oserberg E, Tannir J, Brannigan R. The effect of genital tract infection and inflammation on male infertility. In Lipshultz L, Howards S, Niederberger C, eds. Infertility in the Male, 4th edn. Cambridge: Cambridge University Press, 2009.
43. Krieger JN, Nyberg L, Nickel JC. NIH consensus definition and classification of prostatitis. JAMA 1999; 282: 236–7.
44. Potts JM, Pasqualotto FF. Seminal oxidative stress in patients with chronic prostatitis. Andrologia 2003; 35: 304–8.
45. Turek PJ, Lipshultz LI. Immunologic infertility. Urol Clin North Am 1994; 21: 447–68.
46. Cropp CS, Schlaff WD. Antisperm antibodies. Arch Immunol Ther Exp (Warsz) 1990; 38: 31–46.
47. Haas GG, Manganiello P. A double-blind, placebo-controlled study of the use of methylprednisolone in infertile men with sperm-associated immunoglobulins. Fertil Steril 1987; 47: 295–301.
48. Hendry WF, Hughes L, Scammell G, Pryor JP, Hargreave TB. Comparison of prednisolone and placebo in subfertile men with antibodies to spermatozoa. Lancet 1990; 335: 85–8.

References

1. Noske HD, Weidner W. Varicocele: a historical perspective. World J Urol 1999; 17: 151–7.
2. Tulloch WS. A consideration of sterility factors in light of subsequent pregnancies. Edinburgh Med J 1952;59: 29–34.
3. Benoff S, Gilbert BR. Varicocele and male infertility: part I. Preface. Hum Reprod Update 2001;7: 47–54.
4. Meacham RB, Joyce GF, Wise M, et al. Male infertility. J Urol 2007;177: 2058–66.
5. Marmar JL. The pathophysiology of varicoceles in the light of current molecular and genetic information. Hum Reprod Update 2001;7: 461–72.
6. Cockett AT, Takihara H, Cosentino MJ. The varicocele. Fertil Steril 1984;41: 5–11.
7. Hendry WF, Sommerville IF, Hall RR, Pugh RC. Investigation and treatment of the subfertile male. Br J Urol 1973;45: 684–92.
8. Naughton CK, Nangia AK, Agarwal A. Pathophysiology of varicoceles in male infertility. Hum Reprod Update 2001;7: 473–81.
9. Witt MA, Lipshultz LI. Varicocele: a progressive or static lesion? Urology 1993;42: 541–3.
10. Oster J. Varicocele in children and adolescents: an investigation of the incidence among Danish school children. Scand J Urol Nephrol 1971;5: 27–32.
11. Raman JD, Walmsley K, Goldstein M. Inheritance of varicoceles. Urology 2005;65: 1186–9.
12. Mokhtari G, Pourreza F, Falahatkar S, Kamran AN, Jamali M. Comparison of prevalence of varicocele in first-degree relatives of patients with varicocele and male kidney donors. Urology 2008;71: 666–8.
13. Schoor RA, Elhanbly SM, Niederberger C. The pathophysiology of varicocele-associated male infertility. Curr Urol Rep 2001;2: 432–6.
14. Jarow JP. Effects of varicocele on male fertility. Hum Reprod Update 2001;7: 59–64.
15. MacLeod J. Seminal cytology in the presence of varicocele. Fertil Steril 1965;16: 735–57.
16. Kruger TF, Menkveld R, Stander FS, et al. Sperm morphologic features as a prognostic factor in in vitro fertilization. Fertil Steril 1986;46: 1118–23.
17. Vazquez-Levin MH, Friedmann P, Goldberg SI, Medley NE, Nagler HM. Response of routine semen analysis and critical assessment of sperm morphology by Kruger classification to therapeutic varicocelectomy. J Urol 1997;158: 1804–7.
18. Simşek F, Türkeri L, Cevik I, Bircan K, Akdaş A. Role of apoptosis in testicular tissue damage caused by varicocele. Arch Esp Urol 1998;51: 947–50.
19. Barqawi A, Caruso A, Meacham RB. Experimental varicocele induces testicular germ cell apoptosis in the rat. J Urol 2004;171: 501–3.
20. Glazier DB, Marmar JL, Diamond SM, Gibbs M, Corson SL. A modified acrosome induction test. Arch Androl 2000;44: 59–64.
21. Vigil P, Wöhler C, Bustos-Obregón E, Comhaire F, Morales P. Assessment of sperm function in fertile and infertile men. Andrologia 1994;26: 55–60.
22. Fuse H, Iwasaki M, Mizuno I, Ikehara-Kawauchi Y. Evaluation of acrosome reactivity using the Acrobeads test in varicocele patients: findings before and after treatment. Arch Androl 2003;49: 1–6.
23. Nilsson S, Edvinsson A, Nilsson B. Improvement of semen and pregnancy rate after ligation and division of the internal spermatic vein: fact or fiction? Br J Urol 1979;51: 591–6.
24. Breznik R, Vlaisavljevic V, Borko E. Treatment of varicocele and male fertility. Arch Androl 1993;30: 157–60.
25. Madgar I, Weissenberg R, Lunenfeld B, Karasik A, Goldwasser B. Controlled trial of high spermatic vein ligation for varicocele in infertile men. Fertil Steril 1995;63: 120–4.
26. Yamamoto M, Hibi H, Hirata Y, Miyake K, Ishigaki T. Effect of varicocelectomy on sperm parameters and pregnancy rate in patients with subclinical varicocele: a randomized prospective controlled study. J Urol 1996;155: 1636–8.
27. Nieschlag E, Hertle L, Fischedick A, Abshagen K, Behre HM. Update on treatment of varicocele: counselling as effective as occlusion of the vena spermatica. Hum Reprod 1998;13: 2147–50.
28. Grasso M, Lania C, Castelli M, et al. Low-grade left varicocele in patients over 30 years old: the effect of spermatic vein ligation on fertility. BJU Int 2000;85: 305–7.
29. Unal D, Yeni E, Verit A, Karatas OF. Clomiphene citrate versus varicocelectomy in treatment of subclinical varicocele: a prospective randomized study. Int J Urol 2001;8: 227–30.
30. Krause W, Müller HH, Schäfer H, Weidner W. Does treatment of varicocele improve male fertility? Results of the “Deutsche Varikozelenstudie”, a multicentre study of 14 collaborating centres. Andrologia 2002;34: 164–71.
31. Abdel-Meguid TA, Al-Sayyad A, Tayib A, Farsi HM. Does varicocele repair improve male infertility? An evidence-based perspective from a randomized, controlled trial. Eur Urol 2011;59: 455–61.
32. Matthews GJ, Matthews ED, Goldstein M. Induction of spermatogenesis and achievement of pregnancy after microsurgical varicocelectomy in men with azoospermia and severe oligoasthenospermia. Fertil Steril 1998;70: 71–5.
33. Kim ED, Leibman BB, Grinblat DM, Lipshultz LI. Varicocele repair improves semen parameters in azoospermic men with spermatogenic failure. J Urol 1999;162: 737–40.
34. Kadioglu A, Tefekli A, Cayan S, et al. Microsurgical inguinal varicocele repair in azoospermic men. Urology 2001;57: 328–33.
35. Cakan M, Altug U. Induction of spermatogenesis by inguinal varicocele repair in azoospermic men. Arch Androl 2004;50: 145–50.
36. Schlegel PN, Kaufmann J. Role of varicocelectomy in men with nonobstructive azoospermia. Fertil Steril 2004;81: 1585–8.
37. Esteves SC, Glina S. Recovery of spermatogenesis after microsurgical subinguinal varicocele repair in azoospermic men based on testicular histology. Int Braz J Urol 2005;31: 541–8.
38. Gat Y, Bachar GN, Everaert K, Levinger U, Gornish M. Induction of spermatogenesis in azoospermic men after internal spermatic vein embolization for the treatment of varicocele. Hum Reprod 2005;20: 1013–17.
39. Poulakis V, Ferakis N, de Vries R, Witzsch U, Becht E. Induction of spermatogenesis in men with azoospermia or severe oligoteratoasthenospermia after antegrade internal spermatic vein sclerotherapy for the treatment of varicocele. Asian J Androl 2006;8: 613–19.
40. Pasqualotto FF, Sobreiro BP, Hallak J, Pasqualotto EB, Lucon AM. Induction of spermatogenesis in azoospermic men after varicocelectomy repair: an update. Fertil Steril 2006;85: 635–9.
41. Ishikawa T, Kondo Y, Yamaguchi K, Sakamoto Y, Fujisawa M. Effect of varicocelectomy on patients with unobstructive azoospermia and severe oligospermia. BJU Int 2008;101: 216–18.
42. Lee JS, Park HJ, Seo JT. What is the indication of varicocelectomy in men with nonobstructive azoospermia? Urology 2007;69: 352–5.
43. Mieusset R, Bujan L, Mansat A, Pontonnier F, Grandjean H. Effects of artificial cryptorchidism on sperm morphology. Fertil Steril 1987;47: 150–5.
44. Mieusset R, Grandjean H, Mansat A, Pontonnier F. Inhibiting effect of artificial cryptorchidism on spermatogenesis. Fertil Steril 1985;43: 589–94.
45. Liu YX. Temperature control of spermatogenesis and prospect of male contraception. Front Biosci (Schol Ed) 2010; 2: 730–55.
46. Shefi S, Tarapore PE, Walsh TJ, Croughan M, Turek PJ. Wet heat exposure: a potentially reversible cause of low semen quality in infertile men. Int Braz J Urol 2007;33: 50–6.
47. Sweeney TE, Rozum JS, Gore RW. Alteration of testicular microvascular pressures during venous pressure elevation. Am J Physiol 1995;269: H37–45.
48. Sweeney TE, Rozum JS, Desjardins C, Gore RW. Microvascular pressure distribution in the hamster testis. Am J Physiol 1991;260: H1581–9.
49. Comhaire F, Vermeulen A. Plasma testosterone in patients with varicocele and sexual inadequacy. J Clin Endocrinol Metab 1975;40: 824–9.
50. Hudson RW. Free sex steroid and sex hormone-binding globulin levels in oligozoospermic men with varicoceles. Fertil Steril 1996;66: 299–304.
51. Younes AK. Low plasma testosterone in varicocele patients with impotence and male infertility. Arch Androl 2000;45: 187–95.
52. Gat Y, Gornish M, Belenky A, Bachar GN. Elevation of serum testosterone and free testosterone after embolization of the internal spermatic vein for the treatment of varicocele in infertile men. Hum Reprod 2004;19: 2303–6.
53. Pirke KM, Vogt HJ, Sintermann R, Spyra B. Testosterone in peripheral plasma, spermatic vein and in testicular tissue under basal conditions and after HCG-stimulation in patients with varicocele. Andrologia 1983;15: 637–41.
54. Haans LC, Laven JS, Mali WP, te Velde ER, Wensing CJ. Testis volumes, semen quality, and hormonal patterns in adolescents with and without a varicocele. Fertil Steril 1991;56: 731–6.
55. The influence of varicocele on parameters of fertility in a large group of men presenting to infertility clinics. World Health Organization. Fertil Steril 1992;57: 1289–93.
56. Alvarez JG, Touchstone JC, Blasco L, Storey BT. Spontaneous lipid peroxidation and production of hydrogen peroxide and superoxide in human spermatozoa. Superoxide dismutase as major enzyme protectant against oxygen toxicity. J Androl 1987;8: 338–48.
57. Aitken RJ, Clarkson JS. Cellular basis of defective sperm function and its association with the genesis of reactive oxygen species by human spermatozoa. J Reprod Fertil 1987;81: 459–69.
58. Mazzilli F, Rossi T, Marchesini M, Ronconi C, Dondero F. Superoxide anion in human semen related to seminal parameters and clinical aspects. Fertil Steril 1994;62: 862–8.
59. Weese DL, Peaster ML, Himsl KK, et al. Stimulated reactive oxygen species generation in the spermatozoa of infertile men. J Urol 1993;149: 64–7.
60. Cocuzza M, Athayde KS, Agarwal A, et al. Impact of clinical varicocele and testis size on seminal reactive oxygen species levels in a fertile population: a prospective controlled study. Fertil Steril 2008;90: 1103–8.
61. Dubin L, Amelar RD. Etiologic factors in 1294 consecutive cases of male infertility. Fertil Steril 1971;22: 469–74.
62. Skoog SJ, Roberts KP, Goldstein M, Pryor JL. The adolescent varicocele: what's new with an old problem in young patients? Pediatrics 1997;100: 112–21.
63. Jarow JP, Ogle, SR, Eskew LA. Seminal improvement following repair of ultrasound detected subclinical varicoceles. J Urol 1996;155: 1287–90.
64. Demas BE, Hricak H, McClure RD. Varicoceles: radiologic diagnosis and treatment. Radiol Clin North Am 1991;29: 619–27.
65. Practice Committee of American Society for Reproductive Medicine. Report on varicocele and infertility. Fertil Steril 2008;90: S247–9.
66. Laven JS, Haans LC, Mali WP, et al. Effects of varicocele treatment in adolescents: a randomized study. Fertil Steril 1992;58: 756–62.
67. Paduch DA, Niedzielski J. Repair versus observation in adolescent varicocele: a prospective study. J Urol 1997;158: 1128–32.
68. Palomo A. Radical cure of varicocele by a new technique: preliminary report. J Urol 1949;61: 604–7.
69. Cayan S, Shavakhabov S, Kadioglu A. Treatment of palpable varicocele in infertile men: a meta-analysis to define the best technique. J Androl 2009;30: 33–40.
70. Cayan S, Kadioglu TC, Tefekli A, Kadioglu A, Tellaloglu S. Comparison of results and complications of high ligation surgery and microsurgical high inguinal varicocelectomy in the treatment of varicocele. Urology 2000;55: 750–4.
71. Goldstein M, Gilbert BR, Dicker AP, Dwosh J, Gnecco C. Microsurgical inguinal varicocelectomy with delivery of the testis: an artery and lymphatic sparing technique. J Urol 1992;148: 1808–11.
72. Lima SS, Castro MP, Costa OF. A new method for the treatment of varicocele. Andrologia 1978;10: 103–6.
73. Pryor JL, Howards SS. Varicocele. Urol Clin North Am 1987;14: 499–513.
74. Evers JH, Collins J, Clarke J. Surgery or embolisation for varicoceles in subfertile men. Cochrane Database Syst Rev 2009; 1: CD000479.
75. Cayan S, Erdemir F, Ozbey I, et al. Can varicocelectomy significantly change the way couples use assisted reproductive technologies? J Urol 2002;167: 1749–52.
76. Agarwal A, Deepinder F, Cocuzza M, et al. Efficacy of varicocelectomy in improving semen parameters: new meta-analytical approach. Urology 2007;70: 532–8.
77. Marmar JL, Agarwal A, Prabakaran S, et al. Reassessing the value of varicocelectomy as a treatment for male subfertility with a new meta-analysis. Fertil Steril 2007; 88: 639–48.
78. Czaplicki M, Bablok L, Janczewski Z. Varicocelectomy in patients with azoospermia. Arch Androl 1979; 3: 51–5.
79. Weedin JW, Khera M, Lipshultz LI. Varicocele repair in patients with nonobstructive azoospermia: a meta-analysis. J Urol 2010; 183: 2309–15.
80. Pagani R, Brugh VM, Lamb DJ. Y chromosome genes and male infertility. Urol Clin North Am 2002; 29: 745–53.
81. Su LM, Goldstein M, Schlegel PN. The effect of varicocelectomy on serum testosterone levels in infertile men with varicoceles. J Urol 1995; 154: 1752–5.
82. Zohdy W, Ghazi S, Arafa M. Impact of varicocelectomy on gonadal and erectile functions in men with hypogonadism and infertility. J Sex Med 2011; 8: 885–93.
83. Tanrikut C, Goldstein M, Rosoff JS, et al. Varicocele as a risk factor for androgen deficiency and effect of repair. BJU Int 2011; 108: 1480–4.
84. Ishikawa T, Fujisawa M. Varicocele ligation on free testosterone levels in infertile men with varicocele. Arch Androl 50: 2004; 443–8.
85. Cocuzza M, Cocuzza MA, Bragais FM, et al. The role of varicocele repair in the new era of assisted reproductive technology. Clinics (Sao Paulo) 2008; 63: 395–404.
86. Kallen B, Finnstrom O, Lindam A, et al. Cancer risk in children and young adults conceived by in vitro fertilization. Pediatrics 126: 2010; 270–6.
87. Schlegel PN. Is assisted reproduction the optimal treatment for varicocele-associated male infertility? A cost-effectiveness analysis. Urology 49: 1997; 83–90.
88. Meng MV, Greene KL, Turek PJ. Surgery or assisted reproduction? A decision analysis of treatment costs in male infertility. J Urol 174: 2005; 1926–31.
89. Lee R, Li PS, Goldstein M, Schattman G, Schlegel PN. A decision analysis of treatments for nonobstructive azoospermia associated with varicocele. Fertil Steril, 2009; 92: 188–96.

References

1. Sanger WG, Olson JH, Sherman JK. Semen cryobanking for men with cancer: criteria change. Fertil Steril 1992; 58: 1024–7.
2. Agarwal A, Ranganathan P, Kattal N, et al. Fertility after cancer: a prospective review of assisted reproductive outcome with banked semen specimens. Fertil Steril 2004; 81: 342–8.
3. Schmidt KL, Larsen E, Bangsboll S, et al. Assisted reproduction in male cancer survivors: fertility treatment and outcome in 67 couples. Hum Reprod 2004; 19: 2806–10.
4. Hourvitz A, Goldschlag DE, Davis OK, et al. Intracytoplasmic sperm injection (ICSI) using cryopreserved sperm from men with malignant neoplasm yields high pregnancy rates. Fertil Steril 2008; 90: 557–63.
5. McLaughlin EA, Ford WC, Hull MG. Motility characteristics and membrane integrity of cryopreserved human spermatozoa. J Reprod Fertil 1992; 95: 527–34.
6. Yogev L, Kleiman SE, Shabtai E, et al. Long-term cryostorage of sperm in a human sperm bank does not damage progressive motility concentration. Hum Reprod 2010; 25: 1097–103.
7. van Casteren NJ, van Santbrink EJ, van Inzen W, Romijn JC, Dohle GR. Use rate and assisted reproduction technologies outcome of cryopreserved semen from 629 cancer patients. Fertil Steril 2008; 90: 2245–50.
8. Kelleher S, Wishart SM, Liu PY, et al. Long-term outcomes of elective human sperm cryostorage. Hum Reprod 2001; 16: 2632–9.
9. Blackhall FH, Atkinson AD, Maaya MB, et al. Semen cryopreservation, utilisation and reproductive outcome in men treated for Hodgkin's disease. Br J Cancer 2002; 87: 381–4.
10. Ragni G, Somigliana E, Restelli L, et al. Sperm banking and rate of assisted reproduction treatment: insights from a 15-year cryopreservation program for male cancer patients. Cancer 2003; 97: 1624–9.
11. Burrello N, Vicari E, La Vignera S, et al. Effects of anti-neoplastic treatment on sperm aneuploidy rate in patients with testicular tumor: a longitudinal study. J Endocrinol Invest 2011; 34: e121–5.
12. O’Flaherty C, Hales BF, Chan P, Robaire B. Impact of chemotherapeutics and advanced testicular cancer or Hodgkin lymphoma on sperm deoxyribonucleic acid integrity. Fertil Steril 2010; 94: 1374–9.
13. Bieber AM, Marcon L, Hales BF, Robaire B. Effects of chemotherapeutic agents for testicular cancer on the male rat reproductive system, spermatozoa, and fertility. J Androl 2006; 27: 189–200.
14. Vaisheva F, Delbes G, Hales BF, Robaire B. Effects of the chemotherapeutic agents for non-Hodgkin lymphoma, cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP), on the male rat reproductive system and progeny outcome. J Androl 2007; 28: 578–87.
15. Byrne J, Rasmussen SA, Steinhorn SC, et al. Genetic disease in offspring of long-term survivors of childhood and adolescent cancer. Am J Hum Genet 1998; 62: 45–52.
16. Boice JD, Jr., Tawn EJ, Winther JF, et al. Genetic effects of radiotherapy for childhood cancer. Health Phys 2003; 85: 65–80.
17. Winther JF, Boice JD, Mulvihill JJ, et al. Chromosomal abnormalities among offspring of childhood-cancer survivors in Denmark: a population-based study. Am J Hum Genet 2004; 74: 1282–5.
18. Brydoy M, Fossa SD, Klepp O, et al. Paternity following treatment for testicular cancer. J Natl Cancer Inst 2005; 97: 1580–8.
19. Ohl DA, Denil J, Bennett CJ, et al. Electroejaculation following retroperitoneal lymphadenectomy. J Urol 1991; 145: 980–3.
20. Hultling C, Rosenlund B, Tornblom M, et al. Transrectal electroejaculation in combination with in-vitro fertilization: an effective treatment of anejaculatory infertility after testicular cancer. Hum Reprod 1995; 10: 847–50.
21. Chung PH, Palermo G, Schlegel PN, et al. The use of intracytoplasmic sperm injection with electroejaculates from anejaculatory men. Hum Reprod 1998; 13: 1854–8.
22. Rosenlund B, Sjoblom P, Tornblom M, Hultling C, Hillensjo T. In-vitro fertilization and intracytoplasmic sperm injection in the treatment of infertility after testicular cancer. Hum Reprod 1998; 13: 414–18.
23. Schlegel PN. Testicular sperm extraction: microdissection improves sperm yield with minimal tissue excision. Hum Reprod 1999; 14: 131–5.
24. Tsujimura A, Matsumiya K, Miyagawa Y, et al. Conventional multiple or microdissection testicular sperm extraction: a comparative study. Hum Reprod 2002; 17: 2924–9.
25. Su LM, Palermo GD, Goldstein M, et al. Testicular sperm extraction with intracytoplasmic sperm injection for nonobstructive azoospermia: testicular histology can predict success of sperm retrieval. J Urol 1999; 161: 112–16.
26. Ramasamy R, Lin K, Gosden LV, et al. High serum FSH levels in men with nonobstructive azoospermia does not affect success of microdissection testicular sperm extraction. Fertil Steril 2009; 92: 590–3.
27. Ramasamy R, Schlegel PN. Microdissection testicular sperm extraction: effect of prior biopsy on success of sperm retrieval. J Urol 2007; 177: 1447–9.
28. Ramasamy R, Yagan N, Schlegel PN. Structural and functional changes to the testis after conventional versus microdissection testicular sperm extraction. Urology 2005; 65: 1190–4.
29. Hsiao W, Stahl PJ, Osterberg EC, et al. Successful treatment of postchemotherapy azoospermia with microsurgical testicular sperm extraction: the Weill Cornell experience. J Clin Oncol 2011; 29: 1607–11.
30. Damani MN, Master V, Meng MV, et al. Postchemotherapy ejaculatory azoospermia: fatherhood with sperm from testis tissue with intracytoplasmic sperm injection. J Clin Oncol 2002; 20: 930–6.
31. Meseguer M, Garrido N, Remohi J, et al. Testicular sperm extraction (TESE) and ICSI in patients with permanent azoospermia after chemotherapy. Hum Reprod 2003; 18: 1281–5.
32. Shalet SM. Effect of irradiation treatment on gonadal function in men treated for germ cell cancer. Eur Urol 1993; 23: 148–51.
33. Huyghe E, Matsuda T, Daudin M, et al. Fertility after testicular cancer treatments: results of a large multicenter study. Cancer 2004; 100: 732–7.
34. Chan PT, Palermo GD, Veeck LL, Rosenwaks Z, Schlegel PN. Testicular sperm extraction combined with intracytoplasmic sperm injection in the treatment of men with persistent azoospermia postchemotherapy. Cancer 2001; 92: 1632–7.

References

1. Rothman CM. A method for obtaining viable sperm in the postmortem state. Fertil Steril 1980; 34: 512–14.
2. Annas G. Culture of life politics at the bedside: the case of Terry Schiavo. N Engl J Med 2005; 352: 1710–15.
3. Emanuel EJ, Daniels ER, Fairclough DL, Claridge BR. The practice of euthanasia and physician-assisted suicide in the United States: adherence to proposed safeguards and effects on physicians. JAMA 1998; 280: 507–13.
4. Swinn M, Emberton M, Ralph D, Smith M, Serhal P. Retrieving semen from a dead patient: utilitarianism in the absence of definitive guidelines. BMJ 1998; 317: 1583.
5. American Medical Association. Patient physician relationship topics: informed consent, 2010. www.ama-assn.org/ama/pub/physician-resources/legal-topics/patient-physician-relationship-topics/informed-consent.shtml (accessed January 2012).
6. Weber B, Kodama R, Jarvi K. Postmortem sperm retrieval: the Canadian perspective. J Androl 2009; 30: 407–9.
7. Ethics Committee of the American Society for Reproductive Medicine. Ethical considerations of assisted reproductive technologies. Fertil Steril 1999; 67 (5 Suppl 1): 1S–9S.
8. Revised Uniform Anatomical Gift Act, 2006. www.anatomicalgiftact.org (accessed January 2012).
9. Gimbel RW, Strosberg MA, Lehrman SE, Gefenas E, Taft F. Presumed consent and other predictors of cadaveric organ consent in Europe. Prog Transplant 2003; 13: 17–23.
10. Strong C. Gamete retrieval after death or irreversible unconsciousness: what counts as informed consent? Camb Q Healthc Ethics 2006; 15: 161–71.
11. Kramer AC. Sperm retrieval from terminally ill or recently deceased patients: a review. Can J Urol 2009; 16: 4627–31.
12. Mohta M, Sethi A, Tyagi A, Mohta A. Psychological care in trauma patients. Injury 2003; 34: 17–25.
13. Orr RD, Siegler M. Is posthumous semen retrieval ethically permissible? J Med Ethics 2002; 28: 299–302.
14. Strong C, Gingrich JR, Kutteh WH. Ethics of sperm retrieval after death or persistent vegetative state. Hum Reprod 2000; 15: 739–45.
15. Batzer F, Hurwitz J, Caplan A. Postmortem parenthood and the need for a protocol with posthumous sperm procurement. Fertil Steril 2003; 79: 1263–9.
16. Donoso A, Tournaye E, Devroey A. Hum Repr Update 2007; 13: 539–47.
17. Grazi RV, Wolowelsky JB. The use of cryopreserved sperm and pre-embryos in contemporary Jewish law and ethics. Assist Reprod Technol Androl 1995; 8: 53–61.
18. Haas J. Begotten not made: a catholic view of reproductive technology. United States Conference of Catholic Bishops. www.usccb.org/profile/programs/rlp/98rlphaa.shtml (accessed August 2010).
19. Serour GI, Dickens BM. Assisted reproductive developments in the Islamic world. Int J Gynaecol Obstet 2000; 70: 77–86.
20. Van Voorhis B. In vitro fertilization. New Engl J Med 2007; 356: 379–86.
21. Hansen M, Kurinczuk J, Bower C, Webb S. The risk of major birth defects after intracytoplasmic sperm injection and in-vitro fertilization. N Engl J Med 2002; 346: 725–30.
22. Ericson A, Kaillen B. Congenital malformations in infants born after IVF: a population based study. Hum Reprod 2001; 16: 504–9.
23. Halliday J, Oke K, Algar E, Amor D. Beckwith–Wiedemann syndrome and IVF: a case control study. Am J Hum Genet 2004; 75: 526–8.
24. Neumann P, Gharib S, Weinstein M. The cost of a successful delivery with in-vitro fertilization. N Engl J Med 1994; 331: 239–43.
25. Collins J. An international survey of the health economics of IVF and ICSI. Hum Reprod Update 2002; 8: 265–77.
26. Issa M, Hsaio K, Bassel Y, et al. Spermatic cord anesthesia block for scrotal procedures in outpatient care setting. J Urol 2004; 172: 2358–61.
27. Cal Super Ct, Los Angeles County, Nos. P680682 and P680683 (1984).
28. Woodward v. Commissioner of Social Security. 760 N.E.2d 257, 435 Mass. 536 (2002).
29. Crockin SL. Legally speaking. Amer Soc Reprod Med News 2002; Spring: 36.
30. Bahadur, G. Death and conception. Hum Reprod 2002; 17: 2769–75.
31. Human Fertilisation and Embryology Act 1990. http://www.legislation.gov.uk/ukpga/1990/37 (accessed January 2012).
32. Cohen P. Life after death: New York state moves to keep dead men's sperm in the family. New Sci 1998; 157: 23.
33. Landau, R. Posthumous sperm retrieval for the purpose of later insemination or IVF in Israel: an ethical and psychosocial critique. Hum Reprod 2004; 19: 1952–6.
34. Anger J, Gilbert B, Goldstein M. Cryopreservation of sperm: indications, methods, and results. J Urol 2003; 170: 1079–84.
35. Blumenfeld Z. How to preserve fertility in young women exposed to chemotherapy? The role of GnRH agonist cotreatment in addition to cryopreservation of embrya, oocytes, or ovaries. Oncologist 2007; 12: 1067–9.

References

1. Lee SJ, Schover LR, Partridge AH, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 2006; 24: 2917–31.
2. Ethics Committee of the American Society for Reproductive Medicine. Fertility preservation and reproduction in cancer patients. Fertil Steril 2005; 83: 1622–8.
3. Schrader M, Müller M, Straub B, Miller K. The impact of chemotherapy on male fertility: a survey of the biologic basis and clinical aspects. Reproductive Toxicology 2001; 15: 611–17.
4. Pont J, Albrecht W. Fertility after chemotherapy for testicular germ cell cancer. Fertil Steril 1997; 68: 1–5.
5. Naysmith TE, Blake DA, Harvey VJ, Johnson NP. Do men undergoing sterilizing cancer treatments have a fertile future? Hum Reprod 1998; 13: 3250–5.
6. Palermo G, Joris H, Devroey P, Van Steirteghem AC. Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte. Lancet 1992; 340: 17–18.
7. Steptoe PC, Edwards RG. Reimplantation of a human embryo with subsequent tubal pregnancy. Lancet 1976; 307: 880–2.
8. Steptoe PC, Edwards RG. Birth after reimplantation of a human embryo. Lancet 1978; 312: 366.
9. Centers for Disease Control and Prevention. 2007 Assisted Reproductive Technology Report. www.cdc.gov/ART/ART2007 (accessed January 2012).
10. Practice Committee of American Society for Reproductive Medicine. The role of tubal reconstructive surgery in the era of assisted reproductive technologies. Fertil Steril 2008; 90: S250–3.
11. International Committee for Monitoring Assisted Reproductive Technology. World collaborative report on assisted reproductive technology, 2002. Hum Reprod 2009 24: 2310–20.
12. Toya M, Saito H, Ohta N, et al. Moderate and severe endometriosis is associated with alterations in the cell cycle of granulosa cells in patients undergoing in vitro fertilization and embryo transfer. Fertil Steril 2000; 73: 344–50.
13. Marcoux S, Maheux R, Bérubé S. Laparoscopic surgery in infertile women with minimal or mild endometriosis. N Engl J Med 1997; 337: 217–22.
14. Jacobson TZ, Duffy JM, Barlow D, et al. Laparoscopic surgery for subfertility associated with endometriosis. Cochrane Database Syst Rev 2010; 1: CD001398.
15. Tummon IS, Asher LJ, Martin JSB, Tulandi T. Randomized controlled trial of superovulation and insemination for infertility associated with minimal or mild endometriosis. Fertil Steril 1997; 68: 8–12.
16. Messinis IE, Nillius SJ. Comparison between tamoxifen and clomiphene for induction of ovulation. Acta Obstet Gynecol Scand 1982; 61: 377–9.
17. MacDougall MJ, Tan SL, Jacobs HS. In vitro fertilization and the ovarian hyperstimulation syndrome. Hum Reprod 1992; 7: 597–600.
18. Agrawal R, Conway G, Sladkevicius P, et al. Serum vascular endothelial growth factor and Doppler blood flow velocities in in vitro fertilization: relevance to ovarian hyperstimulation syndrome and polycystic ovaries. Fertil Steril 1998; 70: 651–8.
19. Nisker J, Tummon I, Daniel S, Kaplan B, Yuzpe A. Conversion of cycles involving ovarian hyperstimulation with intra-uterine insemination to in-vitro fertilization. Hum Reprod 1994; 9: 406–8.
20. Templeton AA, Penney GC. The incidence, characteristics, and prognosis of patients whose infertility is unexplained. Fertil Steril 1982; 37: 175–82.
21. Ziebe S, Loft A, Petersen JH, et al. Embryo quality and developmental potential is compromised by age. Acta Obstet Gynecol Scand 2001; 80: 169–74.
22. Hull MG, Fleming CF, Hughes AO, McDermott A. The age-related decline in female fecundity: a quantitative controlled study of implanting capacity and survival of individual embryos after in vitro fertilization. Fertil Steril 1996; 65: 783–90.
23. Spandorfer SD, Chung PH, Kligman I, et al. An analysis of the effect of age on implantation rates. J Assist Reprod Genet 2000; 17: 303–6.
24. Liu H-C, Rosenwaks Z. Early pregnancy wastage in IVF (in vitro fertilization) patients. J Assist Reprod Genet 1991; 8: 65–72.
25. Spandorfer SD, Davis OK, Barmat LI, Chung PH, Rosenwaks Z. Relationship between maternal age and aneuploidy in in vitro fertilization pregnancy loss. Fertil Steril 2004; 81: 1265–9.
26. Chang M-Y, Chiang C-H, Hsieh Ts-Ta, Soong Y-K, Hsu K-H. Use of the antral follicle count to predict the outcome of assisted reproductive technologies. Fertil Steril 1998; 69: 505–10.
27. Bancsi LF, Broekmans FJ, Eijkemans MJ, et al. Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve. Fertil Steril 2002; 77: 328–36.
28. Burger H, Cahir N, Robertson D, et al. Serum inhibins A and B fall differentially as FSH rises in perimenopausal women. Clin Endocrinol 1998; 48: 809–13.
29. Cameron TT, O’Shea FC, Rolland JM, et al. Occult ovarian failure: a syndrome of infertility, regular menses, and elevated follicle-stimulating hormone concentrations. J Clin Endocrinol Metab 1988 67: 1190–4.
30. Toner JP, Philput CB, Jones GS, Muasher S. Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age. Fertil Steril 1991; 55: 784–91.
31. Visser JA, Themmen APN. Anti-Müllerian hormone and folliculogenesis. Mol Cell Endocrinol 2005; 234: 81–6.
32. Broer SL, Mol BW, Hendriks D, Broekmans FJ. The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count. Fertil Steril 2009; 91: 705–14.
33. Nelson SM, Yates RW, Lyall H, et al. Anti-Mullerian hormone-based approach to controlled ovarian stimulation for assisted conception. Hum Reprod 2009; 24: 867–75.
34. Gnoth C, Schuring AN, Friol K, et al. Relevance of anti-Mullerian hormone measurement in a routine IVF program. Hum Reprod 2008; 23: 1359–65.
35. Muttukrishna S, Suharjono H, McGarrigle H, Sathanandan M. Inhibin B and anti-Mullerian hormone: markers of ovarian response in IVF/ICSI patients? BJOG 2004; 111: 1248–53.
36. Navot D, Rosenwaks Z, Margalioth EJ. Prognostic assessment of female fecundity. Lancet 1987; 2: 645–7.
37. Jain T, Soules MR, Collins JA. Comparison of basal follicle-stimulating hormone versus the clomiphene citrate challenge test for ovarian reserve screening. Fertil Steril 2004; 82: 180–5.
38. Hendriks DJ, Mol B-WJ, Bancsi LFJMM, te Velde ER, Broekmans FJM. The clomiphene citrate challenge test for the prediction of poor ovarian response and nonpregnancy in patients undergoing in vitro fertilization: a systematic review. Fertil Steril 2006; 86: 807–18.
39. Shufaro Y, Schenker JG. Cryopreservation of human genetic material. Ann N Y Acad Sci 2010; 1205: 220–4.
40. Schlegel P. Nonobstructive azoospermia: a revolutionary surgical approach and results. Sem Reprod Med 2009; 27: 165–70.
41. Garner DK, Weissman A, Howles CM, Shoham , eds. Textbook of Assisted Reproductive Technologies: Laboratory and Clinical Perspectives, 3rd edn. London: Informa Healthcare, 2009.
42. MacLeod JGR. The male factor in fertility and infertility. II. Spermatozoon counts in 1000 men of known fertility and in 1000 cases of infertile marriage. J Urol 1951; 66: 436–49.
43. Smith KD R-RL, Steinberger E. Relation between indices of semen analysis and pregnancy rate in infertile couples. Fertil Steril 1977; 25: 503.
44. Aitken RJ, Baker HWG, Irvine DS. On the nature of semen quality and infertility. Hum Reprod 1995; 10: 248–9.
45. Mortimer D. Sperm recovery techniques to maximize fertilizing capacity. Reprod Fertil Dev 1994; 6: 25–31.
46. Baker TG. A quantitative and cytological study of germ cells in human ovaries. Proc R Soc Lond B Biol Sci 1963; 158: 417–33.
47. Van Voorhis BJ, Thomas M, Surrey ES, Sparks A. What do consistently high-performing in vitro fertilization programs in the U.S. do? Fertil Steril 2010; 94: 1346–9.
48. Tarlatzis BC, Fauser BC, Kolibianakis EM, Diedrich K, Devroey P. GnRH antagonists in ovarian stimulation for IVF. Hum Reprod Update 2006; 12: 333–40.
49. Agrawal R, Tan SL, Wild S, et al. Serum vascular endothelial growth factor concentrations in in vitro fertilization cycles predict the risk of ovarian hyperstimulation syndrome. Fertil Steril 1999; 71: 287–93.
50. Dekel NAE, Goren S, Feldman B, Shalgi R. Mechanism of action of GnRH-induced oocyte maturation. J Reprod Fertil Suppl 1989; 37: 319–27.
51. Kang HJ, Rosenwaks Z. Triploidy: the breakdown of monogamy between sperm and egg. Int J Dev Biol 2008; 52: 449–54.
52. Das S, Blake D, Farquhar C, Seif MM. Assisted hatching on assisted conception (IVF and ICSI). Cochrane Database Syst Rev. 2009; 2: CD001894.
53. Barmat LI, Liu HC, Spandorfer SD, et al. Autologous endometrial co-culture in patients with repeated failures of implantation after in vitro fertilization–embryo transfer. J Assist Reprod Genet 1999; 16: 121–7.
54. Spandorfer SD, Barmat L, Navarro J, et al. Autologous endometrial coculture in patients with a previous history of poor quality embryos. J Assist Reprod Genet 2002; 19: 309–12.
55. Spandorfer SD, Pascal P, Parks J, et al. Autologous endometrial coculture in patients with IVF failure: outcome of the first 1,030 cases. J Reprod Med 2004; 49: 463–7.
56. Spandorfer S, Soslow R, Clark R, et al. Histologic characteristics of the endometrium predicts success when utilizing autologous endometrial coculture in patients with IVF failure. J Assist Reprod Genet 2006; 23: 185–9.
57. Ray PF, Ao A, Taylor DM, Winston RML, Handyside AH. Assessment of the reliability of single blastomere analysis for preimplantation diagnosis of the ΔF508 deletion causing cystic fibrosis in clinical practice. Prenat Diagn 1998; 18: 1402–12.
58. Staessen C, Platteau P, Van Assche E, et al. Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomized controlled trial. Hum Reprod 2004; 19: 2849–58.
59. Mastenbroek S, Twisk M, van Echten-Arends J, et al. In vitro fertilization with preimplantation genetic screening. N Engl J Med 2007; 357: 9–17.
60. Brown J, Buckingham K, Abou-Setta AM, Buckett W. Ultrasound versus “clinical touch” for catheter guidance during embryo transfer in women. Cochrane Database Syst Rev 2010; 1: CD006107.
61. Urman B, Yakin K, Ata B, Isiklar A, Balaban B. Effect of hyaluronan-enriched transfer medium on implantation and pregnancy rates after day 3 and day 5 embryo transfers: a prospective randomized study. Fertil Steril 2008; 90: 604–12.
62. Hourvitz A, Goldschlag DE, Davis OK, et al. Intracytoplasmic sperm injection (ICSI) using cryopreserved sperm from men with malignant neoplasm yields high pregnancy rates. Fertil Steril 2008; 90: 557–63.
63. MacDougall MJ, Tan SL, Balen A, Jacobs HS. A controlled study comparing patients with and without polycystic ovaries undergoing in-vitro fertilization. Hum Reprod 1993; 8: 233–7.
64. Chen D, Burmeister L, Goldschlag D, Rosenwaks Z. Ovarian hyperstimulation syndrome: strategies for prevention. Reprod Biomed Online 2003; 7: 43–9.
65. European Recombinant LH Study Group. Human recombinant luteinizing hormone is as effective as, but safer than, urinary human chorionic gonadotropin in inducing final follicular maturation and ovulation in in vitro fertilization procedures: results of a multicenter double-blind study. J Clin Endocrinol Metab 2001; 86: 2607–18.
66. Ludwig M, Felberbaum RE, Devroey P, et al. Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetrorelix (Cetrotide®) in controlled ovarian stimulation for assisted reproduction. Arch Gynecol Obstet 2000; 264: 29–32.
67. Gomez R, Gonzalez-Izquierdo M, Zimmermann RC, et al. Low-dose dopamine agonist administration blocks vascular endothelial growth factor (VEGF)-mediated vascular hyperpermeability without altering VEGF receptor 2-dependent luteal angiogenesis in a rat ovarian hyperstimulation model. Endocrinology 2006; 147: 5400–11.
68. Alvarez C, Marti-Bonmati L, Novella-Maestre E, et al. Dopamine agonist cabergoline reduces hemoconcentration and ascites in hyperstimulated women undergoing assisted reproduction. J Clin Endocrinol Metab 2007; 92: 2931–7.
69. Carizza C, Abdelmassih V, Abdelmassih S, et al. Cabergoline reduces the early onset of ovarian hyperstimulation syndrome: a prospective randomized study. Reprod Biomed Online 2008; 17: 751–5.
70. The Practice Committee of the American Society for Reproductive Medicine and the Practice Committee of the Society for Assisted Reproductive Technology. Guidelines on number of embryos transferred. Fertil Steril 2009; 92: 1518–19.
71. Roest J, Mous H, Zeilmaker G, Verhoeff A. The incidence of major clinical complications in a Dutch transport IVF programme. Hum Reprod Update 1996; 2: 345–53.
72. Azem F, Yaron Y, Botchan A, et al. Ectopic pregnancy after in vitro fertilization-embryo transfer (IVF-ET): the possible role of the ET technique. J Assist Reprod Genet 1993; 10: 302–4.
73. Chow WH, Daling JR, Cates W, Greenberg RS. Epidemiology of ectopic pregnancy. Epidemiol Rev 1987; 9: 70–94.
74. Marcus SF, Macnamee M, Brinsden P. Pregnancy: heterotopic pregnancies after in-vitro fertilization and embryo transfer. Hum Reprod 1995; 10: 1232–6.
75. Rizk B, Tan SL, Morcos S, et al. Heterotopic pregnancies after in vitro fertilization and embryo transfer. Am J Obstet Gynecol 1991; 164: 161–4.
76. Ochsenkühn R, Strowitzki T, Gurtner M, et al. Pregnancy complications, obstetric risks, and neonatal outcome in singleton and twin pregnancies after GIFT and IVF. Arch Gynecol Obstet 2003; 268: 256–61.
77. Jackson RA, Gibson KA, Wu YW, Croughan MS. Perinatal outcomes in singletons following in vitro fertilization: a meta-analysis. Obstet Gynecol 2004; 103: 551–63.
78. Katalinic A, Rösch C, Ludwig M. Pregnancy course and outcome after intracytoplasmic sperm injection: a controlled, prospective cohort study. Fertil Steril 2004; 81: 1604–16.
79. Allen VM, Wilson RD, Cheung A, Genetics Committee of the Society of Obstetricians and Gynaecologists of Canada (SOGC), Reproductive Endocrinology Infertility Committee of the Society of Obstetricians and Gynaecologists of Canada (SOGC). Pregnancy outcomes after assisted reproductive technology. J Obstet Gynaecol Can 2006; 28: 220–50.
80. Thomson F, Shanbhag S, Templeton A, Bhattacharya S. Obstetric outcome in women with subfertility. BJOG 2005; 112: 632–7.
81. Knoester M, Helmerhorst FM, Vandenbroucke JP, et al. Perinatal outcome, health, growth, and medical care utilization of 5- to 8-year-old intracytoplasmic sperm injection singletons. Fertil Steril 2008; 89: 1133–46.
82. Place I, Englert Y. A prospective longitudinal study of the physical, psychomotor, and intellectual development of singleton children up to 5 years who were conceived by intracytoplasmic sperm injection compared with children conceived spontaneously and by in vitro fertilization. Fertil Steril 2003; 80: 1388–97.
83. Bonduelle M, Ponjaert I, Steirteghem AV, et al. Developmental outcome at 2 years of age for children born after ICSI compared with children born after IVF. Hum Reprod 2003; 18: 342–50.
84. Ponjaert-Kristoffersen I, Tjus T, Nekkebroeck J, et al. Psychological follow-up study of 5-year-old ICSI children. Hum Reprod 2004; 19: 2791–7.